• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » OrbiMed founder Isaly out after harassment allegations

OrbiMed founder Isaly out after harassment allegations

December 8, 2017 By Brad Perriello

OrbiMedOrbiMed founder and managing partner Sam Isaly yesterday stepped down in the wake of sexual harassment allegations lodged by several former employees of the healthcare hedge fund.

In a statement released last night, New York City-based OrbiMed said Isaly is leaving “pursuant to years-long succession planning discussions” and did not address the accusations from six women, first reported this week by STAT.

“I am extremely proud of what my distinguished partners and I have accomplished at OrbiMed and the difference we have made in the lives of patients worldwide,” Isaly said in the statement. “OrbiMed is a strong and vibrant company positioned for continued growth and this is a good time for me to pass the baton to the next generation of leaders.”

OrbiMed said it named a committee of Sven Borho, Carl Gordon and Jonathan Silverstein to take over Isaly’s managing partner duties.

Six former employees accused Isaly, a 72-year-old investor long revered in the biotech community for his ability to pick stocks, of routinely demeaning and harassing women with hardcore pornography and sex toys, STAT reported Dec. 5. Isaly has denied the allegations. The sixth accuser contacted the outlet after that story, requesting anonymity for fear of reprisal by the hedge fund.

Identified yesterday as Yanping Ren, the sixth accuser was a junior in college when she accepted a part-time internship at OrbiMed. Ren told STAT that Isaly routinely delivered vulgar and demeaning comments to women during her 18-month tenure, including remarks about their bodies. At least once a month, she said, she encountered women crying in the bathroom, “always related to something that happened in the office.”

“It was so normal in the company,” Ren told the site. “It was like a fact of life that everyone had to accept. Sam just did what he could get away with.”

The allegations mirror accusations leveled by five former OrbiMed employees about Isaly’s behavior. The story roiled Wall Street, prompting investment firm Eaton Vance to review its arrangement with OrbiMed, which provides it with investment advice, STAT reported earlier this week. OrbiMed said it’s hired an independent law firm to investigate the allegations.

Ren, now 29, told the outlet that she found Isaly’s conduct and its lack of consequences shocking. As her first experience in the world of finance, she assumed it was the norm.

“In college, you kind of hear about how crazy the workplace can be,” Ren said. “So I thought, ‘Oh this is just how it is.'”

Luckily her next job, at Vatera, was the opposite, where her boss was a woman and the culture was one of professionalism and respect, she said.

Although the fund did not respond to questions about Ren’s account, in a statement it said it “takes gender equality seriously and wishes to encourage a supportive work environment and equal opportunity for all employees.”

“When I read that statement, I found it quite funny,” Ren told STAT, “because it’s so far from the truth.”

Filed Under: Wall Street Beat Tagged With: OrbiMed, Venture Capital/Private Equity

In case you missed it

  • FDA authorizes marketing of new device designed to remove dead pancreatic tissue
  • Quidel wins EUA for COVID-19 test with faster runtime
  • New Croatian notified body designated to European MDR
  • FDA adds to pandemic-related shortage list
  • Philips wins $2.8M from DoD for early COVID-19 detection tech
  • MicroVention suing Balt
  • Report: Higher error rate seen in use of pulse oximeters with Black patients
  • Nesos raises $16.5M
  • Medtronic gains Health Canada nod for Micra AV pacemaker
  • FDA clears Rapid Medical steerable neurovascular guidewire
  • 11 COVID-19 therapies you need to know
  • First patients treated with Abiomed ECMO tech
  • BREAKING: Elizabeth Holmes’ trial postponed due to California COVID surge
  • BREAKING: Pfizer’s COVID-19 vaccine receives European authorization
  • The top 5 orthopedic device industry stories of 2020
  • How Dexcom CEO Kevin Sayer is leading the company forward
  • Ensuring safe and effective distribution of COVID-19 vaccines

RSS From Medical Design & Outsourcing

  • New Croatian notified body designated to European MDR
    By Ronald Boumans, Emergo Group UDEM Adriatic d.o.o., based in Zagreb, Croatia, is a new name in the EU Notified Body community. They have been officially listed in the European database for Notified Bodies, NANDO, designated for the upcoming Medical Devices Regulation (EU) 2017/745 (MDR). Their Notified Body number is 2696. UDEM is not listed… […]
  • FDA adds to pandemic-related shortage list
    The FDA today announced new shortages of laboratory testing supplies needed for the COVID-19 pandemic and renewed its shortage listing for several types of personal protective equipment (PPE). Newly categorized as being in short supply are micro-pipettes and what the agency described as general-purpose lab equipment. The FDA renewed its listing of shortages for the… […]
  • Clippard gains patent on isolation valve
    Cincinnati-based Clippard said today that the U.S. Patent and Trademark Office (USPTO) has issued a patent for Clippard’s new Eclipse proportional valve. The patent, “Flow Control Valve Using Ceramic Valve Members,” will expire in 2040. The patent describes the product as “a flow control valve that uses two ceramic members having conforming surfaces which are coupled… […]
  • Honeywell to acquire Sparta Systems for $1.3B
    Honeywell (NYSE:HON) announced today that it will buy Sparta Systems (Hamilton, N.J.) and its medtech and pharma quality management software for $1.3 billion. Officials at Honeywell and Sparta Systems’ current owner New Mountain Capital expect the all-cash deal to close by the end of Q1 2021, pending certain regulatory approvals and other customary closing conditions. The… […]
  • 11 COVID-19 therapies you need to know
    The pharmaceutical industry launched a herculean effort to battle the COVID-19 pandemic early in 2020, developing an array of vaccines and other therapeutics while also identifying existing drugs suitable for treating patients sick with severe coronavirus infections. FDA recently granted emergency authorization to two SARS-CoV-2 vaccines and several other treatments. Here are 11 of the… […]
  • The top 5 orthopedic device industry stories of 2020
    The COVID-19 pandemic presented a host of challenges, but major mergers in the orthopedic device space still got done. A deadly coronavirus pandemic is certainly not a good environment for people to go in for knee and hip surgeries. But even amid a tough business climate, orthopedic device companies worked through big M&A deals, and… […]
  • How Dexcom CEO Kevin Sayer is leading the company forward
    The past year threw the same hurdles in the way of Dexcom that it did every other major company. CEO Kevin Sayer told us how it responded. Like most companies in 2020, Dexcom (NSDQ:DXCM) faced a number of challenges brought on by COVID-19, public unrest and more. Dexcom chairman, president & CEO Kevin Sayer had to… […]
  • Ensuring safe and effective distribution of COVID-19 vaccines
    By Stewart Eisenhart, Emergo Group As governments, industry and other entities begin COVID-19 vaccine distribution efforts worldwide, cold chain management has emerged as a crucial factor for ensuring vaccine safety and effectiveness. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do… […]
  • House Dems subpoena Azar, Redfield on questions of political pressure at CDC
    A Congressional committee subpoenaed top Trump administration officials today, demanding documents they allege could show “extensive” pandemic-related political interference at the CDC. In a letter to Health and Human Services secretary Alex Azar and Centers for Disease Control and Prevention director Dr. Robert Redfield, House Democrats said an investigation showed that efforts to interfere with scientific work… […]
  • Taking the fight to COVID-19 – BD, DHL, Novant on delivering, shipping and administering the vaccine
    This week’s DeviceTalks Weekly Podcasts shares the stories of the front-line professionals who are working to get the new COVID-19 vaccines into the hands – and arms – of the front-line fighters and people at greatest risk. Leading off, Elizabeth Woody, senior vice president, public affairs at BD, explains how the company is preparing for… […]
  • These 10 stories mattered the most for medtech in 2020
    COVID-19 dominated the news, but there was so much more going on in medtech. Let’s face it: These are soul-trying times, and no one is going to miss 2020. We’re leaving behind a year of tragedy and disaster — with the COVID-19 pandemic and its more than 1.6 million deaths (more than 300,000 in the… […]

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2020 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS